Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Sikiric has dedicated over 30 years to studying BPC-157, publishing more than 100 peer-reviewed papers on the compound
In preclinical research, AOD9604 is primarily investigated for its selective lipolytic activitythe ability to stimulate fat breakdown (lipolysis) and inhibit fat synthesis (lipogenesis) without exhibiting the growth-promoting or diabetogenic effects of full-length growth hormone
A discussion with your healthcare provider is crucial to determine the right plan for you
Type: Recombinant research-reagent supplier (academic and industry labs) Purity: Research-grade recombinant, batch-to-batch consistency Third-party testing: In-house QC
Poor appetite
To date, no severe adverse effects have been consistently documented in research settings
